These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1356 related items for PubMed ID: 11193145

  • 1. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG, Goedert M.
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [Abstract] [Full Text] [Related]

  • 2. Parkinson's disease and other alpha-synucleinopathies.
    Goedert M.
    Clin Chem Lab Med; 2001 Apr; 39(4):308-12. PubMed ID: 11388653
    [Abstract] [Full Text] [Related]

  • 3. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.
    Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M.
    Neurosci Lett; 1998 Jul 31; 251(3):205-8. PubMed ID: 9726379
    [Abstract] [Full Text] [Related]

  • 4. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
    Iwatsubo T.
    Rinsho Shinkeigaku; 1999 Dec 31; 39(12):1285-6. PubMed ID: 10791099
    [Abstract] [Full Text] [Related]

  • 5. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T.
    Acta Neuropathol; 2002 Sep 31; 104(3):225-30. PubMed ID: 12172907
    [Abstract] [Full Text] [Related]

  • 6. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):1101-18. PubMed ID: 10434313
    [Abstract] [Full Text] [Related]

  • 7. Neuropathological spectrum of synucleinopathies.
    Jellinger KA.
    Mov Disord; 2003 Sep 29; 18 Suppl 6():S2-12. PubMed ID: 14502650
    [Abstract] [Full Text] [Related]

  • 8. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
    Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M.
    Proc Natl Acad Sci U S A; 1998 May 26; 95(11):6469-73. PubMed ID: 9600990
    [Abstract] [Full Text] [Related]

  • 9. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM.
    Science; 2000 Nov 03; 290(5493):985-9. PubMed ID: 11062131
    [Abstract] [Full Text] [Related]

  • 10. Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease.
    Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL, Brownstein MJ, Polymeropoulos MH.
    Mol Psychiatry; 1998 Nov 03; 3(6):493-9. PubMed ID: 9857974
    [Abstract] [Full Text] [Related]

  • 11. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.
    Crowther RA, Daniel SE, Goedert M.
    Neurosci Lett; 2000 Oct 06; 292(2):128-30. PubMed ID: 10998565
    [Abstract] [Full Text] [Related]

  • 12. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
    Hishikawa N, Niwa J, Doyu M, Ito T, Ishigaki S, Hashizume Y, Sobue G.
    Am J Pathol; 2003 Aug 06; 163(2):609-19. PubMed ID: 12875980
    [Abstract] [Full Text] [Related]

  • 13. Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy.
    Shoji M, Harigaya Y, Sasaki A, Uéda K, Ishiguro K, Matsubara E, Watanabe M, Ikeda M, Kanai M, Tomidokoro Y, Shizuka M, Amari M, Kosaka K, Nakazato Y, Okamoto K, Hirai S.
    J Neurol Neurosurg Psychiatry; 2000 May 06; 68(5):605-8. PubMed ID: 10766891
    [Abstract] [Full Text] [Related]

  • 14. A Drosophila model of Parkinson's disease.
    Feany MB, Bender WW.
    Nature; 2000 Mar 23; 404(6776):394-8. PubMed ID: 10746727
    [Abstract] [Full Text] [Related]

  • 15. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T.
    J Neurol; 2003 Oct 23; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [Abstract] [Full Text] [Related]

  • 16. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.
    Brain Res; 1999 Oct 02; 843(1-2):53-61. PubMed ID: 10528110
    [Abstract] [Full Text] [Related]

  • 17. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry.
    Braak H, Sandmann-Keil D, Gai W, Braak E.
    Neurosci Lett; 1999 Apr 09; 265(1):67-9. PubMed ID: 10327208
    [Abstract] [Full Text] [Related]

  • 18. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.
    Lancet Neurol; 2011 Mar 09; 10(3):230-40. PubMed ID: 21317042
    [Abstract] [Full Text] [Related]

  • 19. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW.
    Mol Neurodegener; 2021 Dec 18; 16(1):83. PubMed ID: 34922583
    [Abstract] [Full Text] [Related]

  • 20. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies.
    Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Højrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, Jensen PH.
    J Biol Chem; 2005 Feb 18; 280(7):5703-15. PubMed ID: 15590652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.